The standard tesamorelin dosage for fat loss is 2 mg injected subcutaneously once daily, typically cycled for 6 months to achieve significant visceral adipose tissue reduction while helping preserve lean muscle mass. In Canada, this dosage mirrors the FDA-approved protocol for HIV-associated lipodystrophy and is widely adopted by researchers exploring body recomposition. Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, stimulates the pituitary to secrete endogenous growth hormone, which in turn promotes lipolysis and inhibits fat accumulation without the anabolic risks of exogenous growth hormone.
Understanding Tesamorelin's Mechanism for Fat Loss and Muscle Sparing
Tesamorelin works by binding to GHRH receptors in the pituitary, triggering a pulse of growth hormone release. This pulse raises insulin-like growth factor 1 (IGF-1) levels, which directly enhances fat oxidation and reduces triglyceride storage in adipocytes. Unlike many fat-loss agents, tesamorelin selectively targets visceral fat, the metabolically active fat surrounding organs, while largely sparing subcutaneous fat. Muscle preservation occurs because the boosted GH/IGF-1 axis supports protein synthesis and nitrogen retention, counteracting the catabolic environment often created by caloric deficits. This dual action makes tesamorelin a compelling option for those aiming to shed abdominal fat without sacrificing hard-earned muscle.
Optimal Tesamorelin Dosage for Fat Loss
The clinically validated tesamorelin dosage is 2 mg per day, administered via subcutaneous injection. This dose was established in Phase III trials for reducing visceral adipose tissue, with significant results seen as early as 12 weeks. Some protocols explore 1 mg daily for milder effects or to assess tolerance, but 2 mg remains the gold standard for measurable fat loss. Injections are typically given in the abdomen, rotating sites to avoid irritation. Reconstitution requires mixing the lyophilized powder with bacteriostatic water; for a 2 mg vial, adding 1 mL yields a concentration of 2 mg/mL, so a full 1 mL syringe delivers the dose. Always use sterile technique and refrigerate reconstituted solution.
Tesamorelin Cycle Length and Expected Timeline
A typical tesamorelin cycle length spans 6 months, with reassessment at the 3-month mark. In studies, participants lost an average of 15-20% of visceral adipose tissue over 26 weeks. Visible changes often begin around week 8-12, with progressive fat loss continuing through the cycle. Cycling off for 4-6 weeks after 6 months helps maintain receptor sensitivity and prevent tachyphylaxis. Some users adopt a 5-days-on, 2-days-off schedule within the cycle to mimic natural GH pulsatility, though daily dosing is standard. For muscle preservation, pairing tesamorelin with resistance training and adequate protein intake amplifies its anti-catabolic effects.
Injecting Tesamorelin: Technique and Timing
Subcutaneous injection is straightforward: pinch a fold of skin on the abdomen, insert the needle at a 45-degree angle, and inject slowly. The best time to inject is typically before bed, as this aligns with the body's natural GH surge during sleep, potentially enhancing fat-burning effects. Some prefer morning administration to avoid sleep disturbances, though this is rare. Consistency is key; missing doses can blunt results. For those new to peptides, our step-by-step reconstitution guide covers essential sterile practices applicable to tesamorelin.
Tesamorelin Fat Loss Results: What to Expect in Canada
In Canadian research contexts, tesamorelin has shown consistent reductions in waist circumference and visceral fat area on CT scans. Users often report a leaner midsection, improved muscle definition, and better insulin sensitivity. Unlike rapid weight loss drugs, tesamorelin's effects are gradual and sustainable, with fat loss averaging 1-2 cm from waist circumference monthly. Combining tesamorelin with a modest calorie deficit and regular exercise yields the best body recomposition outcomes. Note that results vary based on baseline fat levels, age, and adherence.
Muscle Preservation: How Tesamorelin Protects Lean Mass
Tesamorelin's muscle-sparing property stems from its ability to elevate IGF-1 without supraphysiological GH spikes. IGF-1 promotes muscle protein synthesis and inhibits proteolysis, helping maintain lean tissue even during weight loss. In contrast to strict dieting alone, which can cause muscle loss, tesamorelin users often preserve or even slightly increase lean mass. This is particularly valuable for aging individuals or those with metabolic conditions. For a deeper dive into peptide-based muscle recovery, see our BPC-157 5mg dosage guide for muscle recovery.
Potential Side Effects and Safety Considerations
Common side effects include injection site reactions, mild joint pain, and transient water retention. Because tesamorelin raises IGF-1, it may theoretically accelerate growth of pre-existing malignancies, so screening is advised. It is contraindicated in active cancer, pregnancy, and hypersensitivity. Regular monitoring of IGF-1 levels, glucose, and HbA1c is recommended, as GH can induce insulin resistance. However, at 2 mg daily, metabolic effects are generally mild and reversible upon discontinuation. Always consult a healthcare provider before starting.
Tesamorelin vs Other Peptides for Fat Loss
Compared to other peptides, tesamorelin stands out for its targeted visceral fat reduction. Semaglutide and tirzepatide primarily suppress appetite and delay gastric emptying, leading to overall weight loss but not specifically visceral fat. AOD-9604 and HGH Fragment 176-191 mimic the lipolytic portion of GH but lack tesamorelin's robust clinical data. For muscle preservation, tesamorelin outperforms GHRP-6 or ipamorelin because it stimulates a more natural GH pulse. Those interested in comparing tissue repair peptides can explore our BPC-157 vs TB-500 comparison.
Where to Access Tesamorelin in Canada
Tesamorelin is available in Canada through select research peptide suppliers and compounding pharmacies with a prescription. It is not typically covered by provincial health plans for off-label use, so costs range from $300 to $600 per month depending on the source and dosage. Ensure any supplier provides third-party purity testing. For those exploring other peptide options locally, our BPC-157 5mg price guide in Quebec offers insights into the Canadian peptide market.
Frequently Asked Questions
Can tesamorelin be used for general weight loss?
Tesamorelin is specifically indicated for reducing excess visceral fat, not for overall weight loss. It may not significantly change total body weight but can improve body composition.
How long does it take to see results?
Most users notice a reduction in abdominal fat within 3 months, with optimal results after 6 months of consistent use.
Is post-cycle therapy needed?
No PCT is required, but monitoring IGF-1 and metabolic markers post-cycle is prudent. A break of 4-6 weeks between cycles is recommended.
Can women use tesamorelin?
Yes, tesamorelin is used by both men and women. Dosing is the same, but women may be more sensitive to IGF-1 elevation, so starting at 1 mg is an option.
Final Thoughts on Tesamorelin for Body Recomposition
Tesamorelin offers a targeted approach to reducing stubborn visceral fat while preserving muscle, making it a valuable tool in research and clinical settings. Adhering to the 2 mg daily dosage, a 6-month cycle, and proper injection technique maximizes benefits. As with any peptide, quality sourcing and medical oversight are critical. For those in Canada, understanding local availability and pricing ensures a smooth experience. When combined with lifestyle interventions, tesamorelin can significantly enhance body composition outcomes.